Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does acetaminophen affect liver function in alcoholic patients?

Joseph J Saseen1

  • 1Departments of Clinical Pharmacy and Family Medicine, University of Colorado Health Sciences Center, Denver, USA. joseph.saseen@uchsc.edu

The Journal of Family Practice
|March 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

The 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia-Best evidence and practices aligned.

Journal of clinical lipidology·2026
Same author

New Dyslipidemia Guideline Expands Treatment Options and Risk Assessment in Patients With Diabetes and Chronic Kidney Disease.

Journal of the American College of Cardiology·2026
Same author

Importance of Residency Training for the Provision of Comprehensive Clinical Pharmacy Services.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Nonstatins for LDL-C lowering: An expansion whose time has come.

Journal of clinical lipidology·2026
Same author

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023
Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023
Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023
Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023
Same journal

Renewing the dream.

The Journal of family practice·2023
Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023
See all related articles

Acetaminophen (4 g/d) did not harm liver function in alcoholic patients in this study. However, caution is advised for those with existing liver issues or ongoing alcohol consumption, as acetaminophen hepatotoxicity is still possible.

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Acetaminophen (APAP) is a common analgesic, but its hepatotoxicity in alcoholic patients is debated.
  • Case reports suggest a link between acetaminophen use and liver damage in alcoholics, creating a medical myth.
  • Previous studies have not definitively resolved the safety of acetaminophen in this population.

Purpose of the Study:

  • To investigate the effect of daily acetaminophen dosage (4 g/d) on liver function in patients with alcohol use disorder.
  • To evaluate the potential for acetaminophen-induced hepatotoxicity in a controlled study setting.
  • To address the controversy surrounding acetaminophen safety in chronic alcohol consumers.

Main Methods:

  • A randomized study design was employed.

Related Experiment Videos

  • Participants included patients with alcohol use disorder.
  • Liver function was assessed following acetaminophen administration at 4 g/d.

    • Main Results:

    • Acetaminophen at 4 g/d did not significantly affect liver function tests in alcoholic patients during the study period.
    • The findings challenge the widely held belief that acetaminophen use in alcoholics invariably causes hepatotoxicity.
    • The study did not observe acetaminophen-induced liver failure in the studied cohort.

    Conclusions:

    • The data suggest that acetaminophen, at a dosage of 4 g/d, may be safe for short-term use in some alcoholic patients without pre-existing liver disease.
    • The possibility of acetaminophen-induced liver failure cannot be entirely excluded, particularly in patients with compromised liver function or continued heavy alcohol intake.
    • Further patient-oriented research, focusing on chronic use and long-term outcomes, is necessary to fully resolve the controversy regarding acetaminophen hepatotoxicity in alcoholics.